stenting, OTC application and percutaneous placement of drainages resulted in a 100% closure rate. The mortality rate and length of stay were not substantially different after both treatment regimens. Conclusion: Endoscopic management of anastomotic leakages after LRYGB may constitute a valuable alternative therapeutic option to surgical reoperation and drainage placement.
local irrigation and drain placement due to the present inflammatory tissue, which does not allow a repair of the fistula. Alternatively, a renewal of the gastrojejunostomy may be performed [7] . However, with the development of modern endoscopic devices such as covered stents and over-the-scope clips (OTCs), new therapeutic options have become available, but experience with these devices is still limited [8] [9] [10] [11] . Therefore, we retrospectively analyzed the outcome of patients who developed a leak at the gastrojejunal anastomosis after LRYGB and compared the results of surgical and endoscopic treatment strategies.
Material and Methods

Patients and Definitions
Data of 1,046 consecutive patients undergoing an LRYGB from June 2000 to April 2012 were retrospectively analyzed using a prospectively collected database. Patients with anastomotic leakages who received their LRYGB between June 2000 and April 2010 routinely underwent laparoscopic reoperation with either closure of the defect by suture, local irrigation and drainage (n = 7) or renewal of the anastomosis (n = 2). After that, our routine management of leakages at the level of the gastrojejunostomy after LRYGB changed, and we introduced the endoscopic treatment of leakages using sequential or combined application of stents and OTCs. If necessary, additional percutaneous drain placement was performed by interventional radiology (n = 2). Anastomotic leakages at the gastrojejunostomy were diagnosed by upper GI series, computed tomography or upper endoscopy. Outcomes after surgical and endoscopic management were assessed and compared for time between primary LRYGB and diagnosis, patient's characteristics, success rate, time to closure, length of hospital stay and mortality. Time lag from initial procedure (LRYGB) to operative revision defined the closure time in the surgically treated group. Healed leakage was diagnosed endoscopically or by clinical judgment.
Data are presented as mean ± SD, median plus range. Due to the small sample size and distribution, we did not calculate any p values.
Surgery
All LRYGB procedures were performed as described by Wittgrove in 1994. Briefly, a small gastric pouch of approximately 15-25 ml was created and the jejunum divided 50 ml distal to the duodenojejunal flexure. The jejunojejunostomy was performed using a linear stapler. The mesenteric window at the jejunojejunostomy was closed with a non-absorbable suture (Ethibond TM ). Either an alimentary limb length of 150 cm in the proximal bypass or a common channel of 150 cm in the distal bypass was chosen, depending on the preoperative body mass index. The gastrojejunal anastomosis was performed using a circular stapler (CEEA 25 mm, Tyco, Mansfield, Mass., USA). Reoperations were performed laparoscopically including suturing of the leakage if detected early, drainage and irrigation (n = 7) or renewal of the gastrojejunostomy (n = 2).
Endoscopy
Endoscopies were performed under deep conscious sedation with propofol using Olympus endoscopic instruments (Olympus Medical Systems, Tokyo, Japan). Endoscopy was performed together with the bariatric surgeon in the endoscopy unit or bedside in the ICU.
The OTC device has been comprehensively described by its inventors [12] . The system consists of a clip mounted on the distal tip of the endoscope, which can be released by a thread connected through the working channel to the handwheel of the scope. The nitinol clips are highly elastic and have shape memory. Three different sizes of clips are currently available that when closed will cover lesions up to 2-3 cm in diameter depending on the elasticity of tissue. ERCP cannula catheters together with 0.035-inch guide wires are used to detect and visualize fistula orifices and tracts under fluoroscopy. OTCs were placed with the help of different endoscopic equipment. Simple suction, an anchoring device or specially designed forceps called twin grasper were used to grab tissue around the fistula and pull it into the delivery cap of the OTCs. The choice of instrument was at the discretion of the endoscopist.
All stents were placed over a super-stiff Amplatz (Boston Scientific Corp., Natick, Mass., USA) guide wire either under direct visual control by side-by-side endoscopy or assisted by fluoroscopy. We used the following stent types: Ultraflex partially covered SEMS with a diameter of 23/28 mm and length from 9 to 12 cm (Boston Scientific Corp., Natick, Mass., USA) or Niti-S fully covered MEGA or BETA stent (Taewoong Medical, Korea), which are specially designed for leakages after bariatric surgery. Stents were left in place for 2-3 weeks, and then extracted endoscopically using rat tooth forceps. In the same session, reevaluation of the leak was performed and in case of persistence again treated in the abovementioned manner if technically possible.
Results
In total, 1,046 patients underwent LRYGB between June 2000 and April 2012 in our institution, 14 of which developed a leakage at the level of the gastrojejunostomy. Of these, 9 patients were treated surgically and 5 received endoscopic treatment. Patient characteristics of the two groups are shown in table 1 . Surgical treatment consisted of laparoscopic reoperation, defect closure, local irrigation and drain placement (n = 7) or renewal of the gastrojejunostomy (n = 2) and led to successful leak closure in a total of 8 patients (88%). In one patient, however, surgical treatment remained unsuccessful despite a relaparotomy, and the patient died 44 days after the primary operation due to persistent leakage and septicemia.
Endoscopic treatment was performed sequentially and consisted of endoscopic stenting, OTC application and percutaneous placement of drainages if necessary. In total, 6 stents, 10 OTCs and 2 percutaneous drainages were applied sequentially in 5 patients leading to a 100% ( table 2 ) . The approximated mean cost for a patient without a leakage was USD 26,400. In the case of a leakage at the gastrojejunostomy, the cost increased dramatically to USD 80,900. The average cost of the endoscopic treatment per patient including stents and OTC was USD 10,560.
Discussion
The reported incidence of gastrojejunal leakages after LRYGB has been reported to range between 1 and 3% [5] . The management of leakages in obese patients after LRYGB can be complex and technically demanding and results in significant morbidity with prolonged hospital stay in most cases [7] . Early detection and successful management of leakages are therefore crucial in order to achieve a beneficial outcome. Our results suggest that an endoscopic therapy approach consisting of stent and OTC placement may be a valuable alternative to surgical intervention in patients with small leakages and adequate drainage. Further, the endoscopic technique seems to be at least equally safe with a similar success rate when compared to the traditional operative management.
We further observed that the time to closure and length of hospital stay were slightly longer in endoscopically treated patients, highlighting possible limitations of the interventional strategy. However, the definition of the time to closure is difficult, and the interpretation of these results should be taken carefully. Our results are comparable to a recently published study summarizing the results of 7 studies including 67 patients whose leakages after LRYGB were treated with self-expandable stents leading to a success rate of 88% [13] . It was further shown that stent migration was a frequent problem in up to 36% of the cases, especially when fully covered self-expanding stents were used under 'benign' circumstances like leaks and fistulas [14] , which can be observed in up to 42% of cases. In our series, 2 of 6 stents migrated during the course of treatment as documented by endoscopy or radiography. Stent migration might be explained by differences in stent design, which has to be chosen properly. Nowadays, more sophisticated stent models are available, leading to a greater variety of possible choices. Therefore, a case-oriented, tailored approach appears feasible. For example, the first generation of covered stents was predominantly designed for esophageal placement alone. Over time, specially designed anti-migration specifications were added, and uncovered segments were introduced later on to allow tissue overgrowth and therefore hinder migration. Only recently have stents specifically designed for leaks after bariatric surgery become available, providing better anchoring and coverage of complex leaks at the stapler sites [15] .
In our series, we did not observe life-threatening complications of the interventional approach such as formation of abscesses or bleeding. If migrated, stents could be retrieved endoscopically without serious consequences and replaced in the same session.
We are fully aware of the fact that the low number of included patients and the heterogeneous characteristics do not allow any firm conclusion based on the presented results. Thus, the optimal indication and timing of stent and OTC placement still remain unclear and need further investigation.
In conclusion, sequential stent and OTC placement seems to be a valuable therapeutic option for the treat- Values are given as mean ± SD. BMI = Body mass index. 
